GP Pharma is the healthcare arm of GP Group — a trusted bridge between global pharmaceutical innovation and regional markets across the Middle East, with more than 28 years of on-the-ground expertise.
GP Group was founded in 1997 with a single private pharmacy in Homs, Syria, by Hussam Fadel. From that starting point the group has grown into an integrated healthcare organisation operating across the Middle East, Africa and Asia.
Today GP Pharma serves as the group's healthcare arm — distributing pharmaceuticals, medical devices and health & wellness products, alongside pharmaceutical plastic manufacturing through the GP Plast division.
Core operations in Syria · Strategic office in Türkiye · Active presence in Saudi Arabia & the UAE · Growing partnerships across Africa & Asia
To ensure reliable access to high-quality pharmaceutical and healthcare products, while building sustainable partnerships and supporting the advancement of healthcare systems across the region.
To become a key healthcare partner in the Middle East and emerging markets — bridging global pharmaceutical innovation with local market needs, and contributing to sustainable, long-term growth in regional healthcare.
We combine strategic pharmaceutical distribution with specialised pharma plastic manufacturing — delivering an end-to-end healthcare solution.
Strategic distribution of pharmaceuticals, medical devices and health products across Syria, Saudi Arabia, the UAE and wider MENA markets.
Specialised manufacturing of plastic packages and containers for pharmaceutical, healthcare and personal care products, to international quality standards.
Representation and distribution of a broad spectrum of pharmaceutical products.
Distribution of medical equipment and devices across multiple specialties.
Comprehensive health support products for diverse patient populations.
Full-spectrum support for manufacturing and distribution partners.
Over nearly three decades we have built a broad and reliable portfolio — spanning locally manufactured generics, internationally sourced specialties, medical devices and wellness products.
Over 400 prescription generic products distributed on behalf of leading local Syrian manufacturers — covering a broad spectrum of therapeutic areas.
Over 20 internationally sourced oncology products covering core chemotherapy protocols — Cisplatin, Carboplatin, Paclitaxel, Doxorubicin, Methotrexate, Gemcitabine, 5-FU, Oxaliplatin, Irinotecan and more.
A comprehensive range of supplements and vitamins across multiple forms — tablets, capsules, soft gels, syrups, creams, gummies, lollipops and drinkable vials.
A curated line of medically formulated skincare and haircare — creams, shampoos, hair dyes, gels, soaps, medicated toothpastes and certified sun protection.
Essential clinical devices including syringes, cardiac catheters, cardiac valves, oxygenators and dialysis filters — serving surgical, interventional and critical care settings.
A diverse selection of hormonal medications addressing endocrine disorders, alongside a dedicated insulin range for long-term hormonal and metabolic management.
A complete supply of pharmaceutical products for hospital wards, operating theatres and intensive care units — so clinical teams have reliable access to the medicines they need most.
Essential paediatric vaccines, seasonal immunisations and antivenom products, alongside immunological therapies targeting immune-mediated and autoimmune conditions.
These govern every decision we make, every partnership we build, and every product we deliver to the patient.
Ethical distribution practices fully aligned with local and international regulatory requirements.
Full compliance with GSP international standards, ensuring product integrity at every step of the supply chain.
Continuously seeking new partnerships and technologies to stay ahead in a rapidly evolving healthcare landscape.
Long-term relationships with manufacturers, distributors and healthcare institutions — built on mutual respect.
The patient is at the heart of every decision — improving access to quality care is the ultimate purpose of everything we do.
We operate in some of the most complex and dynamic markets in the region. Our field expertise and local relationships are a genuine advantage that cannot be replicated overnight.
With the conflict phase drawing to a close and reconstruction under way, Syria stands at the threshold of a healthcare renaissance. Years of suppressed demand for quality medicines and equipment have created enormous, ready-to-absorb market potential — and the healthcare infrastructure requires comprehensive rehabilitation from the ground up.
Years of scarce, quality pharmaceutical products have created a large, ready-to-respond demand the moment supply becomes available.
Hospitals and health centres need complete re-equipping from scratch — a genuine opportunity for devices and consumables.
Those who enter now build brand loyalty before the market becomes crowded — an advantage that cannot be purchased later.
Increasing facilitations for foreign product registration as part of the broader reactivation of the healthcare sector.
As an international partner you do not need to build your presence from scratch in a complex, high-context market. We provide the complete infrastructure — licences, network, field knowledge and institutional trust — while you focus on what you excel at: manufacturing and quality.
Two commitments run in parallel — the standards we hold ourselves to today, and the capacity we are building for tomorrow.
Whether you are an international manufacturer seeking a trusted distributor, a healthcare institution looking for quality products, or an investor who sees the opportunity in this region — we are here to talk.